USC Michelson Center CSI-Cancer

April 2020 Update

Our mission today, as always, is to understand cancer and improve patient outcomes through our science, research, and development. During and after the COVID-19 pandemic, it is even more urgent than ever that we support cancer patients through the comprehensive liquid biopsy and sophisticated mathematical models to diagnose, prognose, and predict their future in the context of available treatment options and their personal health status.

Link to full document: